| | Insulin Receptor Inhibitors
- AG 538
A potent, competitive inhibitor of IGF-1 receptor kinase (IC50 = 400 nM). | Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-203807 | 133550-18-2 | C16H1NO5 | 5 mg |
- AG 1024
A specific inhibitor of insulin-like growth factor-1 (IGF-1) and insulin receptor tyrosine kinase activity. Exhibits lower IC50 values for IGF-1 than for the insulin receptor. Also inhibits insulin-stimulated cellular proliferation.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-205907 | 65678-07-1 | C14H13BrN2O | 1 mg |
- AGL 2263
A cell-permeable benzoxazolone-containing bioisostere of tyrphostin AG 538 that acts as a potent, substrate-competitive, but not ATP-competitive, inhibitor of insulin receptor (IR) and insulin-like growth factor-1 receptor (IGF-1R).| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-221223 | n.n. | C17H10N2O5 | 5 mg |
- Chromeceptin
Cell-permeable benzochromene. Blocks insulin-induced adipogenesis in 3T3-L1 cells. Suppresses IGF2-dependent growth of HepG2 cells. Binds MFP-2. Activates STAT6-mediated gene expression.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-202540 | 331859-86-0 | C19H16F3N3O | 5 mg |
- IGF-1R Inhibitor, PPP
An insulin-like, cell-permeable compound that acts as a non-competitive, potent, and specific inhibitor of IGF-1R, without affecting IR, FGFR, PDGFR, EGFR, microtubules, or DNA topoisomerase II.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-204008 | 477-47-4 | C22H22O8•xH2O | 10 mg/1 mg |
|